Trial · NCT01052012
Results by group72
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 72
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Pain Intensity on Movement | Cohort 1-POSIMIR | 4.9 | 95% Confidence Interval 4.0 to 5.7 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 1-Bupivacaine HCl | 5.0 | 95% Confidence Interval 4.7 to 6.8 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 2-POSIMIR | 2.8 | 95% Confidence Interval 2.0 to 3.6 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 2-Bupivacaine HCl | 3.9 | 95% Confidence Interval 3.0 to 4.8 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 3-POSIMIR | 4.8 | 95% Confidence Interval 4.4 to 5.2 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 3-Placebo | 5.1 | 95% Confidence Interval 4.7 to 5.6 | score on a scale | |
| Supplemental Opioid Use | Cohort 1-POSIMIR | 87.0 | Inter-Quartile Range 30.0 to 157.0 | Milligram equivalents | |
| Supplemental Opioid Use | Cohort 1-Bupivacaine HCl | 63.0 | Inter-Quartile Range 34.0 to 152.0 | Milligram equivalents | |
| Supplemental Opioid Use | Cohort 2-POSIMIR | 17.0 | Inter-Quartile Range 8.0 to 26.0 | Milligram equivalents | |
| Supplemental Opioid Use | Cohort 2-Bupivacaine HCl | 22.5 | Inter-Quartile Range 12.5 to 34.5 | Milligram equivalents | |
| Supplemental Opioid Use | Cohort 3-POSIMIR | 52.0 | Inter-Quartile Range 24.0 to 86.6 | Milligram equivalents | |
| Supplemental Opioid Use | Cohort 3-Placebo | 62.0 | Inter-Quartile Range 24.0 to 86.0 | Milligram equivalents | |
| Mean Pain Intensity on Movement | Cohort 1-POSIMIR | 5.2 | 95% Confidence Interval 4.4 to 6.1 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 1-Bupivacaine HCl | 6.0 | 95% Confidence Interval 5.0 to 7.0 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 2-POSIMIR | 3.2 | 95% Confidence Interval 2.5 to 4.0 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 2-Bupivacaine HCl | 4.4 | 95% Confidence Interval 3.5 to 5.3 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 3-POSIMIR | 5.2 | 95% Confidence Interval 4.8 to 5.5 | score on a scale | |
| Mean Pain Intensity on Movement | Cohort 3-Placebo | 5.5 | 95% Confidence Interval 5.0 to 5.9 | score on a scale | |
| Total Morphine-equivalent Dose | Cohort 1-POSIMIR | 69.5 | Inter-Quartile Range 25.0 to 133.0 | mg IV Morphine equivalents | |
| Total Morphine-equivalent Dose | Cohort 1-Bupivacaine HCl | 52.0 | Inter-Quartile Range 29.0 to 122.0 | mg IV Morphine equivalents |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01052012/results